title: [Administration of afala preparation in urological practice].
abstract: Our studies of afala in patients with prostatic adenoma demonstrate that afala reduces irritative disorders of urination. Effect of this drug is seen in 98.3% patients during 4 weeks of its use. In longer intake the effect becomes stronger. The dose of 6 tablets a day significantly improves life quality. Three times a day dose is more effective in elimination of nicturia, enhances urine flow rate. Thus, choice of afala dose depends on the symptoms. Afala is indicated for prophylaxis in patients with initial stage of prostatic adenoma and as an alternative to expectation policy.
authors: A I
authors: AI
authors: Neĭmark
authors: V I
authors: VI
authors: Isaenko
authors: Ia V
authors: IaV
authors: Iakovets
authors: A V
authors: AV
authors: Simashkevich
authors: R T
authors: RT
authors: Aliev
mesh_terms: D000368:Aged; D000906:Antibodies / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D008875:Middle Aged; D009929:Organ Size / Q000187:drug effects; D011467:Prostate / Q000187:drug effects*; D017430:Prostate-Specific Antigen / Q000097:blood / Q000276:immunology; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy*; D011788:Quality of Life; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D014555:Urination Disorders / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000906:Antibodies; C533336:afala; D017430:Prostate-Specific Antigen